First scientific literature AI agent from a publisher on AWS to debut at the 7th annual AWS Life Sciences Symposium tomorrow
HOBOKEN, N.J.--(BUSINESS WIRE)-- Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in research and learning, today announces a new collaboration with Amazon Web Services (AWS) to launch a generative AI agent for scientific literature search on AWS. The first of its kind from a publisher on AWS, the AI agent will be unveiled at the 7th annual AWS Life Sciences Symposium in New York City on May 6. The AI agent will demonstrate how researchers can conduct comprehensive full-text scientific literature search across Wiley's extensive journal content, moving beyond traditional abstract-only searches to access detailed content within main sections like methods and results.
The new Wiley literature search agent is available as part of an open source toolkit for healthcare and life sciences agents that has been assembled by AWS. The toolkit offers a catalog of starter agents and an orchestration framework for organizations to build and customize their agentic systems, supporting use cases from biomarker discovery to clinical trial protocol generation. The new AI agent currently includes AI searchable access to articles under the creative commons license, such as Cancer Medicine, delivering reliable and cited insights in minutes rather than the current hours- to days-long manual process of discovering and perusing dozens of articles for relevant information.
"Our collaboration with AWS demonstrates how researchers can access and leverage scientific literature to power more effective discovery across the life sciences sector," said Josh Jarrett, SVP and GM of AI Growth for Wiley. "By integrating Wiley's authoritative full-text content into AWS's technology built on Bedrock Agents, we're showcasing the potential of comprehensive literature search to accelerate innovation and bring critical scientific insights directly into researchers' existing workflows."
"We're excited to work with Wiley to explore how AI-powered agents can enrich evidence-based research with dynamic, detailed, and verifiable scientific content," said Dan Sheeran, General Manager, Healthcare and Life Sciences, AWS. "The cure for cancer isn't going to come from an abstract, but will be derived from researchers interrogating and synthesizing internal and external data. This collaboration demonstrates how customized AI agents with trusted information sources like Wiley's research content can enable life sciences researchers to build these more powerful and informed discovery systems."
Wiley's development of this AI agent demonstrates the company's commitment to building innovative AI solutions while maintaining responsible AI practices through established core principles focusing on the importance of human oversight, transparency, attribution, fairness, and appropriate governance.
Life sciences professionals can learn more about this collaboration at the AWS Life Sciences Symposium on Tuesday, May 6.
About Wiley
Wiley (NYSE: WLY) is one of the world's largest publishers and a trusted leader in research and learning. Our industry-leading content, services, platforms, and knowledge networks are tailored to meet the evolving needs of our customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. We empower knowledge-seekers to transform today's biggest obstacles into tomorrow's brightest opportunities. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com
